Adult Hepatocellular Carcinoma Completed Phase 2 Trials for Tegafur (DB09256)

Also known as: Hepatocellular Carcinoma, Adult / Adult hepatocellular carcinoma (disorder)

IndicationStatusPhase
DBCOND0040123 (Adult Hepatocellular Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02447679Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma RecurrencePrevention